Log in
Register|
varsha chungde ☆ India, 2018-10-08 11:34 (923 d 19:39 ago) Posting: # 19415 Views: 2,775 |
|
|
Hi all, As per guideline we need not to perform any Bioequivalence studies for Injectables. But Enoxaparin sodium being a biologically derived product, is there any need of performing the BA-BE studies. Does the guideline differs for a biologically derived product?  confused: |
|
Helmut ★★★   Vienna, Austria, 2018-10-08 11:53 (923 d 19:20 ago) @ varsha chungde Posting: # 19416 Views: 2,518 |
|
|
Hi Varsha, » As per guideline we need not to perform any Bioequivalence studies for Injectables. It’s not that simple. See e.g., the EMA’s GL page 23. » But Enoxaparin sodium being a biologically derived product, is there any need of performing the BA-BE studies. That’s not the point. See the FDA’s guidance for conditions whether the in vivo PD (!) study can be waived. » Does the guideline differs for a biologically derived product? Differ to what? To get an idea, see the EMA’s guidelines on biosimilars. — Dif-tor heh smusma 🖖 Helmut Schütz ![[image]](https://static.bebac.at/img/CC by.png) The quality of responses received is directly proportional to the quality of the question asked. 🚮 Science Quotes |
|
nobody nothing 2018-10-09 10:42 (922 d 20:31 ago) @ varsha chungde Posting: # 19418 Views: 2,405 |
|
|
» As per guideline we need not to perform any Bioequivalence studies for Injectables. That's simply not true at all. There is a (draft) US guidance on BE for enoxaparine. Good starting point. Have fun! — Kindest regards, nobody |
|
varsha chungde ☆ India, 2018-10-10 07:09 (922 d 00:04 ago) @ nobody Posting: # 19423 Views: 2,327 |
|
|
» There is a (draft) US guidance on BE for enoxaparine. Good starting point. Have fun! The draft guidance says that we need to prove the sameness between API. Edit: Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post #5! [Helmut] |
|
ElMaestro ★★★ Denmark, 2018-10-09 11:13 (922 d 20:01 ago) @ varsha chungde Posting: # 19419 Views: 2,409 |
|
|
Hello varsha, » As per guideline we need not to perform any Bioequivalence studies for Injectables. You mean solutions.  — Pass or fail! ElMaestro |
|
varsha chungde ☆ India, 2018-10-10 07:11 (922 d 00:02 ago) @ ElMaestro Posting: # 19424 Views: 2,353 |
|
|
» You mean solutions. Yes i mean injectable aqueous solution. As enoxaparin injection is API in aqueous solution. But enoxaparin being a biotech product, i just needed an clarification. Do we need to prove our AP to be similar or good enough to waive the BE studies. Edit 2018-10-10 07:14: The draft guidance also says to prove the sameness of API. [Varsha] Edit: Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post #5! Merged with a later (deleted) post. You can edit your post within 24 hours. [Helmut] |
Ing. Helmut Schütz